PeptideJournal
PeptideJournal is a private, local-only tracking app for peptide dosing, inventory management, and protocol scheduling on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive load of manual concentration and dose calculations for users managing complex, multi-vial research protocols.
For Individuals managing complex peptide protocols who prioritize data privacy and require precise, local-only tracking tools.
Key features
Interactive tool for planning vial concentration and dose volumes, serving as a retention lever by providing high-utility precision.
Calculates exact doses via interactive syringe gauge, reducing user error in manual tracking.
Tracks remaining volume and dose counts for single and combo vials with low-stock alerts.
How much does it cost?
The paid model positions the app as a private, utility-focused tool without recurring subscription costs.
Velocity
Active developmentShow more...
5 versions in history. Development pace: active.
Who built it?
User Sentiment
What do users think recently?
Review voice lately leans excited. Users appreciate the integrated calculator and calendar tools simplify complex dosing schedules for researchers tracking multiple substances and clean interface design allows users to manage research logs and inventory without unnecessary cognitive load.
How are ratings & reviews evolving?
What users say, by theme
- The integrated calculator and calendar tools simplify complex dosing schedules for researchers tracking multiple substances
- Clean interface design allows users to manage research logs and inventory without unnecessary cognitive load
- Scheduling logic errors cause duplicate entries for single doses, creating confusion in daily tracking workflows
7 of 7 recent reviews analyzed · limited sample · Excited overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for PeptideJournal
How's the Health & Fitness market?
PeptideJournal maintains a niche position in the Health & Fitness category, currently ranking #55 Paid in the US category. The lack of recent updates (158 days since last store update) suggests a maintenance-mode posture that may limit growth against more active rivals.
Read the market outlookThe rivals identified
By David Dzeveckij
Both apps target users managing peptide protocols, with Peptide Tracker & Calculator offering a free, high-volume alternative to PeptideJournal's paid, privacy-focused model.
- Peptide Tracker & Calculator uses a free model compared to PeptideJournal's $5.99 one-time purchase.
- Peptide Tracker & Calculator explicitly lists support for GLP-1 agonists and healing peptides in its description.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for PeptideJournal
Where is it heading?
The peptide-tracking market is consolidating around tools that offer both precision and reliability. PeptideJournal's current maintenance-mode posture leaves it exposed to rivals that offer more frequent updates and robust scheduling features, which are essential for long-term protocol adherence.
- The 158-day update gap suggests a maintenance-only posture, which erodes user trust in the app's long-term viability for research tracking.
- Scheduling logic errors in the current version cause duplicate calendar entries, directly frustrating the daily adherence tracking workflow.
The SWOT
- Local-only data architecture ensures privacy-first compliance
- Precision-focused calculator tools drive daily reliance
- Adding multi-day protocol cycles would capture power users
- Implementing CSV-based cloud backup would mitigate data-loss risks
Next best moves
Rebuild calendar scheduling logic because duplicate entries are the #1 reported workflow frustration → improve daily retention
+ 1 more prioritized moveThe counter-intuitive read
Users report: The app's lack of cloud sync…
Read the full takeSince the last report: PeptideJournal has formalized its market position as a privacy-focused, one-time purchase tool while surfacing critical user friction regarding calendar scheduling logic. The app remains in a maintenance-only state, with no new feature releases despite the identification of specific workflow bugs.
Bottom line
PeptideJournal's precision tools retain core users, but the lack of updates and scheduling bugs create a churn risk. Fixing the calendar logic would stabilize the experience, allowing the app to defend its niche against more active competitors.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated